About our Guidelines

Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases.

For those with slower machines or internet connections, please see our plain text version of the Guidelines listing.

You will find three styles of guideline:

BSH Guideline (previously known as BCSH Guidelines)
Evidence-based guideline developed following a professional literature search and a review of the evidence by the writing group.

BSH Good Practice Paper
Used to recommend good practice in areas where there is a less robust evidence base but for which a degree of consensus or uniformity is likely to be beneficial to patient care.

BSH Position Paper
The adoption and adaptation of a non-UK evidence-based guideline for use in the UK.

Join BSH to get advance previews and to input into Guidelines via our "sounding board".

See the list of archived BSH Guidelines or modify your communications preferences to receive up-to-date news and information on BSH Guidelines.

The copyright for the guidelines and the material in the guidelines (which includes the text, tables, photographs, images and figures) is owned by Wiley. For the avoidance of doubt, you must not reproduce any part of the guidelines without prior permission from Wiley. You may request permission to use the copyright materials in these guidelines by emailing [email protected]

Please note that we cannot provide clinical advice on the guidelines to members of the public.

If you have any suggestions for new guidelines or have any guideline enquiries please contact Rita Gupta (Guidelines Programme Manager) by email [email protected]

Future Guidelines Writing Group Members Needed: Lymphomas (nodal, extrandal and splenic)

Haematology Oncology Task Force Vacancy

The Haematology-Oncology Task Force of the British Society for Haematology Guidelines (BSH Guidelines) requires one new member. In order to complement other interests in the group, a subspecialty interest in either myeloma or myeloproliferative disease is preferred, or more a more general haemato-oncology background. Currently, lymphoid interest is well catered for.

The appointments will be for 3 years in the first instance. Applications are requested from consultant haematologists or clinical scientists involved in Haemato-Oncology. You will need to be working in a UK hospital and interested in joining the Task Force.

The Task Force meets three times annually via Zoom Video Conferencing. The work of the taskforce is mostly in producing and updating guidelines and addressing other areas of development relevant to the UK. Being part of this group offers an excellent opportunity to help advance a career.

To register your interest please send your CV and covering letter to Rita Gupta, BSH Guidelines Programme Manager: [email protected] by Tuesday, 31 May 2022.

General Haematology Task Force Vacancy

The General Haematology Task Force of the British Society for Haematology Guidelines (BSH Guidelines) requires one new member.

This is a fantastic opportunity to help influence and contribute to haematology clinical guidelines which are used by haematologists around the world and published in The British Journal of Haematology as well as on our website. The work of the taskforce is mostly producing, updating and commenting on BSH guidelines. The Task Force meets three times annually via Zoom Video Conferencing.

Applications are requested from consultant haematologists or clinical scientists with a special interest in non-malignant haematological disorders, who work in a UK hospital. The appointment will be for 3 years in the first instance.

To register your interest please send your CV and covering letter to Rita Gupta, BSH Guidelines Programme Manager: [email protected] by Friday 30 September 2022.

Transfusion Task Force Vacancy

The Transfusion Task Force of the British Society for Haematology Guidelines (BSH Guidelines) requires one new member.

The appointments will be for 3 years in the first instance. Applications are requested from consultant haematologists or clinical scientists involved in Transfusion. You will need to be working in a UK hospital and interested in joining the Task Force.

To register your interest please send your CV and covering letter to Rita Gupta, BSH Guidelines Programme Manager: [email protected] by Friday, 31st December 2021.

ASM Guidelines Session Video 2021 available for viewing

Guidelines Session presentation from the Virtual Annual Scientific Meeting 2021.

Haemostasis and Thrombosis

Draft Guideline on Clinical and laboratory diagnosis of heritable platelet disorders ~ Keith Gomez (To be published summer 2021)

Draft Guideline on the Assessment of bleeding risk prior to surgery or invasive procedures

(To be published 2021)~ Will Lester

Haemostasis and Thrombosis Question and Answer

General Haematology

Draft Guidelines on Management of Sickle Cell Disease in Pregnancy ~ Eugene Oteng-Ntim (To be published summer 2021)

Draft Good Practice Paper: Genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms

~ Nick Cross (To be published 2021)

General Haematology Question and Answer